wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38745816-16DE2B13-9E0A-4479-8E69-7A4F55D082E4
Q38745816-16DE2B13-9E0A-4479-8E69-7A4F55D082E4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38745816-16DE2B13-9E0A-4479-8E69-7A4F55D082E4
Addition of the p110α inhibitor BYL719 overcomes targeted therapy resistance in cells from Her2-positive-PTEN-loss breast cancer.
P2860
Q38745816-16DE2B13-9E0A-4479-8E69-7A4F55D082E4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38745816-16DE2B13-9E0A-4479-8E69-7A4F55D082E4
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ef4ca3adbc90104c98938c89c4e81c39a4c92a3d
P2860
Human target validation of phosphoinositide 3-kinase (PI3K)β: effects on platelets and insulin sensitivity, using AZD6482 a novel PI3Kβ inhibitor.